
ab115732 at 2.5ug/ml staining Nova1 in Human brain (cortex) tissue by immunohistochemistry (FFPE). Following primary incubation slides were incubated with biotinylated anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

ab115732 at 2.5ug/ml staining Nova1 in Human heart tissue by immunohistochemistry (FFPE). Following primary incubation slides were incubated with biotinylated anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

Anti-Nova1 antibody (ab115732) at 0.01 µg/ml + Human breast cancer lysate (in RIPA buffer) at 35 µgdeveloped using the ECL technique